97.7 B&H Clinic under STC Life Successfully Treats Hair Loss Patient
July 21, 2014
Stem Cell Treatment & Research Institute (STRI) and 97.7 B&H Clinic under STC Life announced that they have successfully regenerated hair from a patient suffering from Alopecia Universalis, using the Newly Elicited Pluripotent Stem Cells without side effects by natural compound (STC-nEPS) derived from human umbilical cord.
Stem cells, immature cells whose differentiation is still ongoing, possess the ability to differentiate into different cells including neuron, skin cell, hemangiocyte, and liver cell. STC-MSC (Mesenchymal Stem Cells), isolated by Dr. Lee Sang-hyun’s team at the Stem Cell Treatment &Research Institute (STRI) under STC Life, is a progenitor stem cell that exists inside an organ tissue which make up a human body and one that carries out and maintains a routine function of different organ tissues. It is known to aide growth and differentiation of different cells and organ cells including regeneration of damaged tissues.
In order to test how STC-MSC influences hair regeneration, researchers at 97.7 B&H Clinic injected the same to an Alopecia Universalis patient, classified as an autoimmune disorder. The patient previously had a hair transplant but hair loss occurred continuously which prevented transplanted hair from growing.
However, after two months of stem cell treatment at the 97.7 B&H Clinic, hair started to grow from the patient’s thinning spots. According to 97.7 B&H Clinic, hair started to grow and the symptoms improved without side-effects.
Based on this outcome, the 97.7 B&H Clinic is working on applying the STC-MSC (Mesenchymal Stem Cells) treatment to regenerate and/ or restore hair follicles from thinning parts. “Cause for Alopecia Universalis remains unknown and it gives much pain to the patients. I hope the latest finding will give much hope to the patients,” remarked Kye-ho Lee, Chairman of STC Life.